Needle free diabetes care Companies
Needle-free innovations. Committed to enhancing the lives of individuals managing diabetes, our cutting-edge technologies provide a comfortable and stress-free approach to glucose monitoring and insulin delivery.
Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Latest Needle-Free Diabetes Care Companies Update
Roche Diabetes Care partners with Dexcom in a landmark collaboration, combining their expertise in insulin pumps and CGM technology to develop next-generation integrated systems for seamless diabetes management. This partnership aims to provide patients with a closed-loop solution that automates insulin delivery based on real-time glucose data.
Insulet Corporation acquires Tandem Diabetes Care, consolidating the insulin pump market and focusing on developing next-generation closed-loop systems. This move strengthens Insulet's position as a leader in tubeless insulin pump technology and expands its reach in the diabetes care market.
Medtronic unveils the MiniMed 780G insulin pump, the first hybrid closed-loop system approved in the US, offering automated insulin adjustments based on CGM data. This breakthrough technology simplifies diabetes management for patients and improves glycemic control.
Patch Pumps Corporation introduces the Omnipod 5 System, featuring an extended wear pump and a mobile app for remote monitoring and bolus delivery. This user-friendly system offers greater convenience and flexibility for insulin-dependent individuals.
CeQur Corporation secures FDA Breakthrough Therapy Designation for its LyoPro insulin patch, paving the way for a potentially transformative needle-free insulin delivery option. This innovative patch eliminates the need for injections and offers sustained insulin release through microneedle technology.
List of Needle-Free Diabetes Care Key Companies in the Market
-
Medical International Technology Inc. (US)
-
European Pharma Group (Netherland)
-
Zogenix Inc. (US)
-
Antares Pharma Inc. (US)
-
Valeritas Inc. (US)
-
3M Company (US)
-
Endo International plc. (US)
-
INJEX Pharma AG (Germany)
-
Bioject Medical Technologies Inc. (US)
-
Crossject SA (France)
-
PharmaJet (US)
-
PenJet Corporation (US)
Needle free diabetes care Market Highlights:
Needle free diabetes care Market Highlights:
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
